Fexofenadine 60mg Tablet Franchise in Ahmedabad

Antihistamine Tablet Supplier in Bangalore

Fexofenadine Tablet Distributor in Hyderabad

Allergy Relief Tablet Franchise Opportunity in Jaipur

Seasonal Allergy Tablet Stockist in Mumbai
Fexofenadine Tablet Export & Manufacturing in Chandigarh

Home/Products /fexofenadine-60mg-tablet

Fexoform 60 Tablet

Composition : Fexofenadine (60mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Fexoform 60 Tablet contains Fexofenadine 60mg, a highly effective second-generation antihistamine that provides rapid relief from allergy symptoms such as sneezing, runny nose, itchy eyes, and hives. Its non-sedating property allows patients to maintain daily activities without drowsiness.

Fexofenadine selectively blocks peripheral H1 receptors, preventing histamine-induced allergic reactions. The 60mg strength offers enhanced symptom control for moderate to severe allergies, making it suitable for both seasonal and chronic conditions.

For hospitals, clinics, and distributors, Fexoform 60 Tablet is a high-rotation allergy-care product, frequently prescribed by general practitioners, ENT specialists, and dermatologists. Continuous allergy prevalence ensures consistent demand and repeat procurement throughout the year.

Adding Fexoform 60 Tablet to your product catalogue strengthens your allergy and ENT-care segment, creating opportunities in hospital supply, pharmacy distribution, institutional procurement, export channels, and third-party manufacturing. Its proven efficacy and patient-friendly profile make it a valuable and profitable addition for pharmaceutical distributors.

Read More

About the Product

Fexoform 60 Tablet contains Fexofenadine 60mg, a highly effective second-generation antihistamine that provides rapid relief from allergy symptoms such as sneezing, runny nose, itchy eyes, and hives. Its non-sedating property allows patients to maintain daily activities without drowsiness.

Fexofenadine selectively blocks peripheral H1 receptors, preventing histamine-induced allergic reactions. The 60mg strength offers enhanced symptom control for moderate to severe allergies, making it suitable for both seasonal and chronic conditions.

For hospitals, clinics, and distributors, Fexoform 60 Tablet is a high-rotation allergy-care product, frequently prescribed by general practitioners, ENT specialists, and dermatologists. Continuous allergy prevalence ensures consistent demand and repeat procurement throughout the year.

Adding Fexoform 60 Tablet to your product catalogue strengthens your allergy and ENT-care segment, creating opportunities in hospital supply, pharmacy distribution, institutional procurement, export channels, and third-party manufacturing. Its proven efficacy and patient-friendly profile make it a valuable and profitable addition for pharmaceutical distributors.

Some patients may experience headache, dizziness, nausea, or mild fatigue. Rarely, allergic reactions or gastrointestinal disturbances may occur.

Fexoform 60 Tablet is indicated for the relief of seasonal and perennial allergic rhinitis, chronic urticaria, and other histamine-mediated allergic conditions. It helps alleviate symptoms like watery eyes, nasal congestion, itching, and skin hives.

Use strictly under medical supervision. Avoid in patients with known hypersensitivity to Fexofenadine. Consult a doctor before use if taking other medications or fruit juices, as interactions may reduce effectiveness.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation